Navigation Links
Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making
Date:5/27/2009

Five Seasoned CIOs Share Practical Insights on Physician Engagement, Career Success

SCOTTSDALE, Ariz., May 27 /PRNewswire/ -- Carefx Corporation, whose Fusionfx solution suite aggregates patient information across existing systems and offers clinicians single, clinically relevant views of patient information, today released the second in a series of white papers documenting the increasing involvement of healthcare chief information officers (CIOs) and chief medical information officers (CMIOs) in operations and physician engagement and decisions to initiate, postpone or cut IT projects.

"Carefx is proud to have an ongoing role in facilitating dialogue among CIOs and CMIOs who increasingly function as strategists, visionaries and operations executives," said Andrew Hurd, Carefx's Chairman and CEO. "The second Carefx white paper shines a light on professionals who are enthusiastic about newly available IT stimulus funds, but who still face tough financial decisions on IT investments and projects."

The Changing Role of the Healthcare CIO: Expanded Responsibilities in an Era of Economic Constraints was introduced at the April 2009 meeting of the Healthcare Information Management Systems Society (HIMSS) and was complemented by a live CIO/CMIO roundtable where healthcare CIOs and CMIOs shared insights on issues such as data retrieval, shifting roles and business and IT plan integration. These hospital leaders agreed that their ever-expanding roles increasingly involve a great deal of strategic thinking and planning. They also said that they spend much of their time working with clinicians to figure out ways to better utilize the data the organization collects. Said one, "We have spent the last 5 years figuring out how to get data into clinical apps, and now we need to figur
'/>"/>

SOURCE Carefx Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. The Newest High-Tech Home Care Equipment and Services on Display!
4. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
5. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
6. Disability Management Employer Coalition Names Mercer as Newest Platinum Sponsor
7. UCSF Medical Center using newest high-tech tool for brain disorders
8. The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens Newest MRI Technology
9. North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign
10. Doctors: Talk Therapy Newest Hope for Treating One Physical Side Effect of Holiday Blues
11. Highmark to Present States Newest Residents with Healthcare Gift Cards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... Department of Energy has selected a Texas Wind Integration project ... to conduct a regional smart grid demonstration project. Drummond Group,s ... leading the testing efforts with strong support from the project ... ... (PRWEB) December 7, 2009 -- The Department of Energy ...
(Date:12/7/2009)... throughout the Clinical Workflow , ... ... currently using point-of-care resources from EBSCO Publishing ... from a new agreement which gives healthcare providers integrated ... of relevant and current information and improved quality care. ...
(Date:12/7/2009)... AllegroMedical.com partners with Cure to support medical research. , ... ... doing its part to help find a cure for spinal cord ... Cure Catheters to its list of nearly 45,000 products., , ,Cure ... to facilitate finding a cure for spinal cord injury, the company ...
(Date:12/7/2009)... leader in the Collection Industry for the second time this ... in speed, cost, and customer retention. , ... ... leading provider of flat-fee collection services, was recently named one ... This is the second time this year the collection ...
(Date:12/7/2009)... NEW ORLEANS, Dec. 7 Cell Therapeutics, ... that Ruth Pettengell, M.D. of St. George,s Hospital, ... 2009 American Society of Hematology ("ASH") Annual Meeting ... (PIX 301) clinical trial of pixantrone (the "PIX ... non-Hodgkin,s lymphoma ("NHL") patients who have failed ...
Breaking Medicine News(10 mins):Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 2Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 3Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 4Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 2Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 3Health News:Online Medical Supply Superstore Adds Cure Catheters to Product Mix 2Health News:Collection Agency Named One of 2009 Best Places to Work 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5
... ARTICLE #1 FOR IMMEDIATE RELEASE , Sniffing out uses ... 25 years of research, development of an electronic nose even ... chemists in Germany conclude in an overview on the topic. ... the current issue of ACS monthly journal Chemical Reviews. , ...
... Addressing Physicians-in-Training, HOUSTON, March 10 More ... American Medical Student,Association,s (AMSA) 58th annual convention, set ... in Houston, Texas., Premedical and medical students, ... activists from across the,country will assemble for "healthcare ...
... Best Non-Branded Web site, Best Branded ... Digital Media Campaign, WEST CONSHOHOCKEN, Pa., March 10 ... the healthcare,industry, announced today it has received multiple nominations ... be announced at the DTC,National Advertising Awards Dinner on ...
... SHENZHEN, China, March 10 /Xinhua-PRNewswire-FirstCall/ -- China,Nepstar Chain ... Company"), the,largest drugstore chain in China based on the ... report financial results for the,fourth quarter and fiscal year ... 19, 2008., The Company will host a conference ...
... ,Wyeth (NYSE: WYE ) announced today that ... nutritional manufacturing facility in Suzhou,Industrial Park, Jiangsu Province, ... milk powder and other nutritional products. When,completed, the ... nutritional,manufacturing facilities., "This investment reflects Wyeth,s long-term ...
... WATERBURY, Conn., March 10 Therap Services announces,the ... Implementation.,Therap Services is a web-based service bureau offering ... community. Therap has a,customer support team consisting of ... professionals., "We are happy to have Anna ...
Other Medicine News:Health News:American Chemical Society's Weekly PressPac -- March 5, 2008 2Health News:American Chemical Society's Weekly PressPac -- March 5, 2008 3Health News:American Chemical Society's Weekly PressPac -- March 5, 2008 4Health News:American Chemical Society's Weekly PressPac -- March 5, 2008 5Health News:American Chemical Society's Weekly PressPac -- March 5, 2008 6Health News:American Chemical Society's Weekly PressPac -- March 5, 2008 7Health News:American Chemical Society's Weekly PressPac -- March 5, 2008 8Health News:American Chemical Society's Weekly PressPac -- March 5, 2008 9Health News:AMSA Annual Convention: Largest Gathering of Medical Students Celebrates 58 Years of Student Activism 2Health News:Cadient Group Receives Multiple Nominations for 2008 DTC National Advertising Awards 2Health News:China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19 2Health News:China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19 3Health News:Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China 2Health News:Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China 3Health News:Therap Services Welcomes Anna Keith to the US Customer Support Team 2
(Date:12/4/2009)... Imaging (TDI), part of a Health & Wellness ... superior quality infrared imaging of the breast, neuromuscular ... assist in the early diagnosis of problems associated ... imaging cameras that "read" the entire infrared range ...
(Date:12/4/2009)... (OTC Bulletin Board: OXBT) today announced that the first ... dose escalation, clinical trial in Switzerland for use of ... the Company,s perfluorocarbon (PFC) therapeutic oxygen carrier. ,, "This ... of patients with severe TBI. We hope to finally ...
(Date:12/4/2009)... LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: ... and medication delivery company, today announced the launch of ... for intravenous (I.V.) medications and solutions, and now offers ... of the award-winning, environmentally responsible VisIV product. The launch ...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 1China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 2China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 3China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 4China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 5China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 6China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 7China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 8China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 9China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 10China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 11China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 12China Nepstar Chain Drugstore Reports 92 1 25 Year on Year Increase in Operating Income for Third Quarter 2009 62316 13Severe asymptomatic heart disease may accompany narrowing in leg arteries 62311 1Severe asymptomatic heart disease may accompany narrowing in leg arteries 62311 2East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 62307 1East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 62307 2East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 62307 3
... 31st European Cystic Fibrosis Conference -, SOUTH ... /PRNewswire/,-- PTC Therapeutics, Inc. (PTC) today announced promising ... fibrosis (CF). Results from an Israeli Phase 2a,extension ... in adult,patients with nonsense-mutation-mediated CF demonstrated statistically,significant improvements ...
... through three years of LymphoStat-B ... infections or laboratory ... abnormalities over time -, ROCKVILLE, Md., June ... the presentation of results,from a long- term Phase 2 continuation trial ...
Other Medicine Technology:PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 2PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 3PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 4PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 5Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 7
... and comfortable eye protection Properly manufactured ... of scatter radiation. Our high quality frames ... comfort with minimized weight. Our lenses are ... that meet all industry standards. Most Pulse ...
... lenses and frames are designed with the safety ... lenses are Schott RS-520 (also called SF-6) leaded ... These lenses meet standards, as set for optical ... ,While our eyewear is protecting your eyes, ...
... Stylish and comfortable eye protection ... approximately 90% of scatter radiation. Our high ... protection and comfort with minimized weight. Our ... leaded) optics that meet all industry standards. ...
Uvex Patriot Frame...
Medicine Products: